4//SEC Filing
RIEDEL NORBERT G 4
Accession 0001437749-24-004358
CIK 0001710340other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:15 PM ET
Size
5.3 KB
Accession
0001437749-24-004358
Insider Transaction Report
Form 4
RIEDEL NORBERT G
Director
Transactions
- Award
Stock Option (Right to buy)
2024-02-13+30,000→ 164,555 totalExercise: $4.42Exp: 2034-02-12→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on February 13, 2025.
Documents
Issuer
Eton Pharmaceuticals, Inc.
CIK 0001710340
Entity typeother
Related Parties
1- filerCIK 0001161662
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:15 PM ET
- Size
- 5.3 KB